Opzelura
The first cream approved to bring color back to vitiligo, and a fast non-steroid option for eczema. It carries a boxed warning borrowed from the tablet versions of the same drug class, and a limit on how much skin you can treat.
Key facts
Opzelura at a glance.
Used for
Vitiligo or mild to moderate eczema
Results
Eczema: sooner; pigment: months
Treatment commitment
Duration depends on the condition
Key precautions
Area limits and immune precautions
What is it?
Top things to know about Opzelura
- It is a topical JAK inhibitor. Ruxolitinib blocks JAK1 and JAK2 immune signaling.
- It treats eczema and vitiligo. It is labeled for mild to moderate eczema from age 2 and vitiligo from age 12.
- The cream and tablet differ. They have different indications and instructions.
- Area limits apply. Quantity limits remain important even for a few patches.
HOW IT WORKS
How Opzelura works
Diagram explanation and sources
Blocks JAK1 and JAK2: Interrupts enzymes that relay inflammatory messages. Calms eczema and itch: Less inflammatory signaling helps irritated skin settle. Helps pigment return: In vitiligo, skin color can recover gradually.
JAK1/JAK2 inhibition is established; the relevance of individual JAK enzymes to therapeutic effectiveness is not fully known. Eczema improvement and vitiligo repigmentation are distinct outcomes, not guaranteed or immediate.
Strengths
Ruxolitinib strengths
Topical ruxolitinib is supplied as 1.5% cream. Its eczema and vitiligo indications have different age, body-area and use limits. The tube percentage does not replace those limits or the product’s boxed warnings.
1.5%
A single cream concentration used for selected atopic dermatitis or nonsegmental vitiligo. Follow the diagnosis-specific label and maximum amount.
Strength sources
Forms
Ruxolitinib forms
Cream
Richer and more moisturizing; often suits dry skin. The full formula still affects comfort.
How to use it
Your treatment, step by step.
How to apply it
- 01
When to Apply
A thin layer twice a day, roughly twelve hours apart, on affected skin only. Wash your hands afterwards unless your hands are being treated. Two limits are on the label, not suggestions: no more than 20% of your body surface at a time, and no more than 60 grams a week, or 100 grams over two weeks. One palm is about 1% of your body surface.
- 02
How to Start
Twice daily from day one. For eczema, keep going until the skin is clear, then stop — the label calls it short-term, on-and-off treatment. For vitiligo it is the opposite: use it steadily. Stopping early is the usual reason it appears not to work.
- 03
If It Irritates
Redness, itch or a mild sting where you apply it is the usual early complaint and it settles. Acne or small bumps at the site is the other common one, most often on the face in vitiligo treatment, and it is treatable rather than a reason to stop. Moisturizing afterwards helps both.
- 04
If It's Not Working
For eczema, reassess at 8 weeks; if the skin is not clear, the label says stop and reconsider. For vitiligo, do not judge before 24 weeks. Repigmentation is slow, it starts on the face, and hands and feet may show very little for a long time. No change by about six months is when your doctor will usually add narrowband UVB light treatment.
Monitoring & follow-up
For most healthy people using it within the label limits, no routine blood tests are needed. Blood levels from the cream are very low, and the trials did not find the blood count or cholesterol changes the tablet causes.
Your doctor monitors the label's safety concerns by asking rather than testing. Expect questions about blood clots, heart attack or stroke, smoking, cancer, tuberculosis exposure, hepatitis, and whether anything else you take suppresses your immune system. This cream is not meant to be combined with other JAK inhibitors, biologics or strong immunosuppressants.
They will check the response on schedule — 8 weeks for eczema, 24 weeks and then longer for vitiligo — and ask about infections, unexplained fever, night sweats, weight loss, chest pain, breathlessness and leg swelling. Some doctors check blood counts and cholesterol at baseline in people with other risk factors.
Skin checks matter for a different reason — unpigmented skin burns easily, so an annual look at the skin is sensible regardless.
What to expect
How things change over time.
Applying it
A thin layer twice a day. Mild stinging or redness where you apply it is the usual side effect.
Adjusting
For eczema, itch often improves within the first few days, sometimes the first day — among the quickest of any topical. For vitiligo, nothing visible yet.
Working, eczema
Redness fades and the rash flattens. Most of the eczema improvement happens here.
Judge it here, eczema
Week 8 is the fair point. If the skin is not clear, the label says stop and reconsider.
Working, vitiligo
The first sign is small pigmented dots inside a patch, often around hairs, which spread and join up. The face and neck move first, and around a third of people reach 75 percent repigmentation of the face by about six months.
Continuing, vitiligo
By about a year roughly half reach that 75 percent mark on the face. The trunk and limbs are slower, and skin with hair does better, because surviving pigment cells live in hair follicles. Where vitiligo is still spreading, the cream helps hold the line.
Watch for
Acne or small bumps at the site. Report any fever, unusual infection, chest pain, breathlessness or swollen painful leg.
- First few minutes
- Days 1 to 7
- Weeks 2 to 4
- Weeks 4 to 8
- Weeks 8 to 24
- Months 6 to 12 and beyond
- Throughout
When you stop
There is no taper and no withdrawal effect. You can stop on any day.
With eczema, the rash generally comes back over days to weeks, because the drug treats the inflammation and not the underlying tendency. The treatment is designed to be used in courses.
Vitiligo is different. Pigment that has come back tends to stay. What can return is the immune attack, so patches may start losing color again, and in trials many people who stopped lost ground over the following months. So vitiligo treatment is usually continued long term, or tapered slowly under supervision.
What it Pairs with
Opzelura + your routine
| Product or situation | With Opzelura | What to know |
|---|---|---|
| What to know | Avoid | Going over the area limit. No more than 20% of your body surface at a time. One palm is roughly 1%, so 20% is about twenty palms' worth. More raises how much reaches your bloodstream. |
| What to know | Avoid | Going over the amount limit. No more than 60 grams a week, or 100 grams over two weeks. If you run out faster, tell your doctor rather than stretch the dose. |
| What to know | Avoid | Continuous use for eczema without review. The label describes short courses — different from vitiligo, where steady long-term use is the point. |
| What to know | Avoid | Applying it to infected skin. Treat cold sores, impetigo, shingles or a fungal rash first. Calming the local immune response over an untreated infection lets it spread. |
| What to know | Avoid | Covering it with an airtight dressing. Occlusion increases absorption. |
| What to know | Avoid | Live vaccines while using it. Plan this with your doctor. Routine non-live vaccines, including most flu shots, are not the concern. |
| What to know | Avoid | Expecting sunscreen to be optional. Newly repigmented skin and unpigmented patches both burn easily. |
| If you are pregnant or breastfeeding | Use care | this includes planning a pregnancy. Ask the doctor managing your pregnancy before starting or continuing. Keep it off the breast and nipple while breastfeeding. |
| If you have had a blood clot or stroke | Use care | a heart attack, or smoking, counts too. These are the boxed warning risks, and they change how the decision is weighed. |
| If you have had cancer | Use care | including skin cancer. Discuss it before starting. |
| If you have had tuberculosis or hepatitis | Use care | hepatitis B and C count, and so does being around someone with active tuberculosis. Your doctor may want testing first. |
| If you take another JAK inhibitor | Use care | a biologic or a strong immunosuppressant counts too. The label advises against combining these. |
| If your immune system is weakened | Use care | by a transplant, chemotherapy, HIV or long-term immune-suppressing treatment, this cream is not approved for the eczema use. |
| If you develop a fever or night sweats | Use care | unusual tiredness, or an infection that will not clear, counts too. Report it rather than wait. |
| If you get chest pain or breathlessness | Use care | one-sided weakness, slurred speech, or a swollen painful leg counts too. Seek urgent care. |
| If you need a live vaccine | Use care | plan the timing with your doctor. |
| If you need more than one tube a week | Use care | say so, rather than rationing or quietly exceeding the limit. |
Getting it and cost
Getting Opzelura.
Cost & access
Cost is the honest sticking point. Ruxolitinib cream is brand only with no generic, and a 60-gram tube lists at a few thousand dollars. Since a tube is one week's maximum, sustained use is expensive at list price.
What affects the cost
Almost nobody pays that, but almost everybody has to work for coverage. A prior authorization is standard. For eczema, plans typically want a topical steroid and often a calcineurin inhibitor tried first. For vitiligo, coverage has been harder because some plans treat it as cosmetic — a letter from your dermatologist explaining that vitiligo is an autoimmune disease with real medical and psychological effects is usually what turns that around. Denials are frequently overturned on appeal.
What affects the cost
The manufacturer runs a copay program that can cut the cost a lot with commercial insurance, plus patient assistance for people who qualify. Terms change often. People on government insurance are usually not eligible for copay cards, which is a real gap.
One practical point
the drug is priced by the tube, so treating only the areas that need it is a cost decision as well as a safety rule.
Alternatives
Other options to consider.
Topical steroids
decades of evidence, cheap and fast for eczema, and used off-label for vitiligo. The trade-off is skin thinning with long use, which matters most on the face — exactly where vitiligo is most visible and where treatment is needed longest.
Tacrolimus ointment and pimecrolimus cream
well established for eczema, used off-label for vitiligo, and both avoid skin thinning. They are far cheaper, especially now that generics exist. For vitiligo the evidence is weaker than for ruxolitinib cream and repigmentation is generally slower, though tacrolimus with light treatment has a long track record.
Narrowband UVB light treatment
the most established vitiligo treatment there is, and the combination of light plus a cream generally beats either alone. The trade-off is practical — it usually means two or three clinic visits a week for months.
Roflumilast cream
once daily, no boxed warning, no limit on how much skin you treat, and good evidence in psoriasis and eczema. It is not a vitiligo treatment, which is the main dividing line between the two.
Dupilumab
an injection for moderate to severe eczema, much stronger for widespread disease and used continuously. Different scale of treatment, different cost structure, and not a vitiligo drug.
Questions
Questions you might be asking.
How long before I see color coming back?
Most people see the first small pigmented dots between two and six months, usually on the face and often around hairs. Twenty-four weeks is the earliest fair point to judge, and results keep improving past a year.
Why is there a boxed warning on a cream?
Regulators applied it to the whole drug class after a large safety study of a JAK tablet in older people with rheumatoid arthritis and heart risk factors found more heart events, clots, infections and cancers. The cream's own trials did not show those events, and blood levels from a cream within the limits are a small fraction of a tablet dose.
Why can I only treat 20% of my body?
That limit and the 60 grams a week cap keep the amount reaching your bloodstream low. It is why the safety picture for the cream differs from the tablet.
Will the pigment stay if I stop?
Pigment that has returned usually stays, but the immune attack can restart and patches can begin losing color again. Most people continue treatment or reduce it gradually rather than stopping outright.
Why am I getting spots where I put it on?
Acne at the application site is a recognized side effect, most often on the face during vitiligo treatment. It is treatable and not a reason to stop.
Does it work on hands and feet?
Less well, and more slowly. Areas with few hair follicles have fewer surviving pigment cells to repopulate the skin. The face is where this cream does its best work.
Can I use it with light treatment?
A common combination, often more effective than either alone, but plan it with your dermatologist rather than starting on your own.
Related
